• 2000: Licenciado en Medicina y Cirugía por la Universidad de Santiago de Compostela.
• 2003: Prueba Nacional del sistema de formación MIR.
• 2007: Especialista en Hematología y Hemoterapia. Fundación Jiménez Díaz, Universidad Autónoma de Madrid.
• 2012: DEA Trabajo de Investigación tutelado-Suficiencia Investigadora. Universidad Autónoma de Madrid. 
• 2016: Leukemia and Bone Transplantation Program. Observership University of Texas MD Anderson Cancer Center.
• 2017: 2nd Edition 2016-2017, Master in Bone Marrow Transplantation. Universidad de Valencia
• 2017: Máster en Oncología Molecular MOM (CNIO). Centro Nacional de Investigaciones Oncológicas (CNIO), Centro de Estudios Biosanitarios (CEB) y Universidad Rey Juan Carlos.
• 2017: Taussig Cancer Center. Leukemia and Myeloid Disorders Program. Observership Cleveland Clinic.

• Sociedad española de Hematología y Hemoterapia
• Grupo de Trabajo Leucemias Agudas Madrid
• European Hematology Association
• Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea
• PETHEMA Fundation

PUBLICATIONS:

• Xiao Jun Huang,1 Kaiyan Liu,1 David Ritchie,2 Borje Andersson,3 Jin Lu,1 Jian Hou,4 Adolfo de Fuente Burguera,5 JianXiang Wang,6 Allen Yeoh,26 Chenhua Yan,1 Daobin Zhou,8 Daryl Tan,7 Dong Wook Kim,8 Depei Wu,9 Elizabeth Shpall,3 Stephen Kornblau,3 Sattava Neelapu,3 Suradej Hongeng,10 Jianyong Li,11 Jiong Hu,12 Lian Sheng Zhang,13 Michael Wang,3 Pankaj Malhotra,14 Qian Jiang,1 Yazhen Qin,1 Raymond Wong,15 Richard Champlin,3 Frederick Hagemeister,3 Jason Westin,3 Swaminathan Iyer,16 Vikram Mathews,17 Yu Wang,1 Yu Hu,18 Zhijian Xiao,19 Zonghong Shao,20 Robert Z. Orlowski,3 Chor Sang Chim,21 Stephen Mulligan,22 Miguel Sanz,23 Keiya Ozawa,24 Simrit Parmar,3 and Surapol Issaragrisil25 Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China. Oncotarget. 2017 Jun 20; 8(25): 41620–41630.

• Peñalver FJ1, Sancho JM2, de la Fuente A3, Olave MT4, Martín A5, Panizo C6, Pérez E7, Salar A8, Orfao A5; Spanish Lymphoma Group (GELTAMO). Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO). Haematologica. 2017 Feb;102(2):235-245. doi: 10.3324/haematol.2016.149120. Epub 2016 Oct 20

• Peñalver FJ, Delgado J, Loscertales J, Sastre JL, Peña A, Olave MT, Osorio S, de la Fuente A, Salar A, Grande C, Pérez Ceballos E, Debén G, Echeveste A, Casado F, de la Rubia J, Lahuerta JJ, Mateos MV. Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma. Eur J Haematol. 2016 May;96(5):532-40. doi: 10.1111/ejh.12633. Epub 2015 Aug 9.

• Lu J, Hou J, Liu KY, Parmar S, De La Fuente A, Andersson B, Yan C, Zhou D, Tan D, Ritchie D, Wu D, Shpall E, Laport GG, Li J, Hu J, Zhang LS, Wang M, Malhotra P, Jiang Q, Qin Y, Wong R, Champlin R, Issaragrisil S, Iyer S, Mathews V, Wang Y, Hu Y, Xiao Z, Shao Z, Rosengarten R, Steuernagle J, Xiao JH, Orlowski R, Chim CS. Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China. Leuk Lymphoma 57(7):1-5, 7/2016. e-Pub 2/2016. PMID: 26887657.

• Garrote H, de la Fuente A, Oña R, Rodríguez I, Echevarría JE, Sepúlveda JM and García JF. Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia Experimental Hematology & Oncology 2015, 4:8 (1 March 2015)

• Bennett TA1, Montesinos P2, Moscardo F2, Martinez-Cuadron D2, Martinez J3, Sierra J4, García R5, de Oteyza JP6, Fernandez P7, Serrano J8, Fernandez A9, Herrera P10, Gonzalez A11, Bethancourt C12, Rodriguez-Macias G13, Alonso A14, Vera JA15, Navas B16, Lavilla E17, Lopez JA18, Jimenez S19, Simiele A20, Vidriales B21, Gonzalez BJ22, Burgaleta C23, Hernandez Rivas JA24, Mascuñano RC25, Bautista G26, Perez Simon JA27, de la Fuente A28, Rayón C29, Troconiz IF30, Janda A30, Bosanquet AG31, Hernandez-Campo P1, Primo D1, Lopez R1, Liebana B1, Rojas JL1, Gorrochategui J1, Sanz MA2, Ballesteros J32. Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: a bridge to individualized medicine.Clin Lymphoma Myeloma Leuk. 2014 Aug;14(4):305-18 doi: 10.1016/j.clml.2013.11.006. Epub 2013 Nov 15.

• Loeffler endocarditis: Wath have we learned. Juan Benezet-Mazuecos, Adolfo de la Fuente, Pedro Maros-Alberca, Jerónimo Farre. Loeffler endocarditis: Wath have we learned. American Journal of Hematology. 2007 Oct;82(10):861-2.

• Benezet-Mazuecos J. De la Fuente A Electrocardiographic findings after acute absinthe intoxication.International Journal of Cardiology 2006. I. J. Cardiology 2006 Nov 10;113(2):e48-50

• Juan Benezet-Mazuecos, Pedro Marcos-Alberca, Jeronimo Farre, Miguel Orejas, Adolfo de la Fuente, and Elena Prieto. Early differential resolution of right and left ventricular obliteration in Löffler endocarditis after chemotherapy and anticoagulation. CIRCULATION AHA/2006 Circulation.2006 Dec 12; 114: e635-e637